Latest News

FDA asks for additional data to approve Evenity in US

Pharmaceutical companies Amgen and UCB have received a Complete Response Letter from the US Food and Drug Administration (FDA) for Evenity, a treatment for postmenopausal women with...

FDA asks for additional data to approve Evenity in US

UDG Healthcare to acquire Cambridge BioMarketing for up to $35m

International healthcare services provider UDG Healthcare has agreed to acquire US-based healthcare communications business Cambridge BioMarketing for a total consideration of up to...

UDG Healthcare to acquire Cambridge BioMarketing for up to $35m

AstraZeneca signs deal to sell commercial rights for Seloken in Europe

AstraZeneca has entered an agreement to provide the commercial rights for Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax...

AstraZeneca signs deal to sell commercial rights for Seloken in Europe

NPPA issues notice to pharmaceutical firms for non-compliance of pricing provisions

Indian drug price regulator the National Pharmaceutical Pricing Authority (NPPA) has issued notices to several pharmaceutical companies that have marketed combination drugs without complying...

NPPA issues notice to pharmaceutical firms for non-compliance of pricing provisions

Thermo Fisher Scientific agrees to buy Patheon for $7.2bn

Thermo Fisher Scientific agrees to buy Patheon for $7.2bn

Synthetic Biologics’ SYN-004 secures FDA breakthrough therapy status

Synthetic Biologics’ SYN-004 secures FDA breakthrough therapy status

Novartis and Pakistan sign deal to provide free medicine for chronic diseases

Ministry of National Health Services, Regulations and Coordination of Pakistan and Novartis have signed a memorandum of understanding (MoU) to increase access to treatment for poor people...

Novartis and Pakistan sign deal to provide free medicine for chronic diseases

Celyad receives FDA fast-track status for C-Cure to treat ischemic heart failure

Celyad receives FDA fast-track status for C-Cure to treat ischemic heart failure

Norgine agrees to buy Merus Labs for $342m

Norgine has entered a definitive agreement to acquire all issued and outstanding common shares of Merus Labs International for $1.65 per share in cash, including the assumption of all...

Norgine agrees to buy Merus Labs for $342m

Takeda signs collaboration deal with GammaDelta Therapeutics for T-cell therapy

Takeda Pharmaceutical Company has entered a strategic collaboration with Abingworth portfolio company GammaDelta Therapeutics to develop a T-cell platform based on distinct properties of...

Takeda signs collaboration deal with GammaDelta Therapeutics for T-cell therapy

Study finds painkillers increase heart attack risk within first week of use

A new study carried out by an international team of researchers found that non-steroidal anti-inflammatory drugs (NSAIDs), commonly known as painkillers, can increase the risk of heart...

Study finds painkillers increase heart attack risk within first week of use

FDA approves Bavencio for advanced bladder cancer treatment

FDA approves Bavencio for advanced bladder cancer treatment

Novartis receives FDA approval for Kisqali Femara Co-Pack to treat metastatic breast cancer

Novartis has received the US Food and Drug Administration (FDA) approval for the Kisqali Femara Co-Pack to treat hormone receptor-positive, human epidermal growth factor receptor-2...

Novartis receives FDA approval for Kisqali Femara Co-Pack to treat metastatic breast cancer

EUSA Pharma receives EC approval for dinutuximab beta antibody to treat neuroblastoma

EUSA Pharma receives EC approval for dinutuximab beta antibody to treat neuroblastoma

MT Pharma America's Radicava secures FDA approval to treat ALS

MT Pharma America has secured the US Food and Drug Administration (FDA) approval for Radicava (edaravone) as an intravenous infusion treatment for patients affected with amyotrophic...

MT Pharma America's Radicava secures FDA approval to treat ALS

Crown Bioscience collaborates with Jiangsu Qyun to develop CTLA-4 Antibody

Crown Bioscience collaborates with Jiangsu Qyun to develop CTLA-4 Antibody

Merck receives EC approval for Keytruda to treat relapsed Hodgkin Lymphoma

Merck receives EC approval for Keytruda to treat relapsed Hodgkin Lymphoma

Proterris and Alfama complete merger to create carbon monoxide therapy leader

Proterris has announced the completion of its merger with Alfama, creating a dominant player in carbon monoxide (CO)...

Proterris and Alfama complete merger to create carbon monoxide therapy leader

Perrigo offices searched by US Justice Department in drug pricing probe

Generics maker Perrigo has reported that its corporate offices were searched by the agents of the US Department of Justice (DOJ) antitrust division as part of an ongoing investigation related...

Perrigo offices searched by US Justice Department in drug pricing probe

AstraZeneca’s Imfinzi receives FDA-accelerated approval for urothelial cancer

AstraZeneca’s Imfinzi receives FDA-accelerated approval for urothelial cancer

US Court of Appeals reverses District Court’s ruling on Aloxi patent

A panel of the United States Court of Appeals for the Federal Circuit has reversed the opinion of the District Court for the District of New Jersey for Aloxi (palonosetron hydrochloride)...

US Court of Appeals reverses District Court’s ruling on Aloxi patent
cachename:Newscachekey:rd-137342983_330948329_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_-1061922081